The GLP-1 drugs covered in the briefing are designed to support individuals dealing with obesity, diabetes, and other metabolic conditions.
According to the administration, the policy changes would reduce costs for oral GLP-1 medications to $149 per month and injectable versions to $249 per month.
Dr. Oz, presenting the plan, remarked that these changes were intended to ease financial strain on patients while improving public health outcomes.
While Trump appeared to briefly slump in his seat, officials noted that he continued to interact with attendees and respond to questions from reporters throughout the event.
Despite the administration’s insistence, critics and commentators seized upon the moment to question whether the former president had the stamina to maintain attention and composure during extended or high-pressure public engagements.

A Week of Chaos in the West Wing
Continue reading…